Novel motif:28: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:38, 9 September 2013
name: | motif28_CGTNCA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0045717 | negative regulation of fatty acid biosynthetic process | 3.733468e-14 |
GO:0002679 | respiratory burst involved in defense response | 6.798469e-14 |
GO:0032425 | positive regulation of mismatch repair | 5.641857e-13 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.072069e-12 |
GO:0051055 | negative regulation of lipid biosynthetic process | 5.340318e-12 |
GO:0002149 | hypochlorous acid biosynthetic process | 2.728592e-11 |
GO:0070593 | dendrite self-avoidance | 2.884488e-10 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 7.245543e-10 |
GO:0010897 | negative regulation of triglyceride catabolic process | 7.245543e-10 |
GO:0051324 | prophase | 1.168052e-9 |
GO:0006544 | glycine metabolic process | 1.416375e-9 |
GO:0008033 | tRNA processing | 4.798926e-9 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 5.549923e-9 |
GO:0043491 | protein kinase B signaling cascade | 9.323696e-9 |
GO:0048842 | positive regulation of axon extension involved in axon guidance | 9.358775e-9 |
GO:0044319 | wound healing, spreading of cells | 9.899007e-9 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 1.394577e-8 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 1.628686e-8 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.198124e-8 |
GO:0006853 | carnitine shuttle | 2.369855e-8 |
GO:0033326 | cerebrospinal fluid secretion | 2.388339e-8 |
GO:0007128 | meiotic prophase I | 2.442803e-8 |
GO:0032423 | regulation of mismatch repair | 2.570585e-8 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 2.873193e-8 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 2.952761e-8 |
GO:0085029 | extracellular matrix assembly | 4.274179e-8 |
GO:0048251 | elastic fiber assembly | 6.056817e-8 |
GO:0051084 | 'de novo' posttranslational protein folding | 6.081851e-8 |
GO:0042304 | regulation of fatty acid biosynthetic process | 6.273020e-8 |
GO:0010625 | positive regulation of Schwann cell proliferation | 6.758248e-8 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 7.371648e-8 |
GO:0071279 | cellular response to cobalt ion | 7.491433e-8 |
GO:0010637 | negative regulation of mitochondrial fusion | 7.491433e-8 |
GO:0010624 | regulation of Schwann cell proliferation | 8.675090e-8 |
GO:0035313 | wound healing, spreading of epidermal cells | 9.842609e-8 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.745757e-7 |
GO:0010934 | macrophage cytokine production | 1.747450e-7 |
GO:0006458 | 'de novo' protein folding | 2.375313e-7 |
GO:0006548 | histidine catabolic process | 2.681145e-7 |
GO:0042744 | hydrogen peroxide catabolic process | 3.863836e-7 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 4.668258e-7 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 5.981314e-7 |
GO:0060710 | chorio-allantoic fusion | 6.965627e-7 |
GO:0045833 | negative regulation of lipid metabolic process | 7.828728e-7 |
GO:0090239 | regulation of histone H4 acetylation | 7.979181e-7 |
GO:0046890 | regulation of lipid biosynthetic process | 8.572866e-7 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 8.841879e-7 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 8.861970e-7 |
GO:0009069 | serine family amino acid metabolic process | 9.109268e-7 |
GO:0010544 | negative regulation of platelet activation | 9.841139e-7 |
GO:0009071 | serine family amino acid catabolic process | 1.015105e-6 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.141827e-6 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 2.091135e-6 |
GO:0007283 | spermatogenesis | 2.605487e-6 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 2.711488e-6 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 2.786334e-6 |
GO:0009070 | serine family amino acid biosynthetic process | 3.201900e-6 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 3.590683e-6 |
GO:0071071 | regulation of phospholipid biosynthetic process | 3.726856e-6 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 3.757629e-6 |
GO:0071034 | CUT catabolic process | 3.937510e-6 |
GO:0043206 | fibril organization | 4.094278e-6 |
GO:0090241 | negative regulation of histone H4 acetylation | 4.804362e-6 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 4.804362e-6 |
GO:0032971 | regulation of muscle filament sliding | 4.981619e-6 |
GO:0034969 | histone arginine methylation | 5.313166e-6 |
GO:0007635 | chemosensory behavior | 5.812276e-6 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 5.992475e-6 |
GO:0050434 | positive regulation of viral transcription | 6.074878e-6 |
GO:0060252 | positive regulation of glial cell proliferation | 6.478071e-6 |
GO:0006545 | glycine biosynthetic process | 6.580953e-6 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 6.653743e-6 |
GO:0006547 | histidine metabolic process | 6.959632e-6 |
GO:0045793 | positive regulation of cell size | 7.071715e-6 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 7.931108e-6 |
GO:0006635 | fatty acid beta-oxidation | 8.445077e-6 |
GO:0018195 | peptidyl-arginine modification | 9.601444e-6 |
GO:0007506 | gonadal mesoderm development | 1.002833e-5 |
GO:0045112 | integrin biosynthetic process | 1.007131e-5 |
GO:0051788 | response to misfolded protein | 1.023860e-5 |
GO:0070979 | protein K11-linked ubiquitination | 1.026161e-5 |
GO:0006563 | L-serine metabolic process | 1.060889e-5 |
GO:0033590 | response to cobalamin | 1.131745e-5 |
GO:0006117 | acetaldehyde metabolic process | 1.131745e-5 |
GO:0045652 | regulation of megakaryocyte differentiation | 1.248592e-5 |
GO:0015879 | carnitine transport | 1.248592e-5 |
GO:0018216 | peptidyl-arginine methylation | 1.265583e-5 |
GO:0060689 | cell differentiation involved in salivary gland development | 1.353637e-5 |
GO:0071333 | cellular response to glucose stimulus | 1.382882e-5 |
GO:0048050 | post-embryonic eye morphogenesis | 1.431210e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.431210e-5 |
GO:0009235 | cobalamin metabolic process | 1.489223e-5 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.507146e-5 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.535656e-5 |
GO:2000573 | positive regulation of DNA biosynthetic process | 1.575700e-5 |
GO:0006457 | protein folding | 1.641137e-5 |
GO:0046782 | regulation of viral transcription | 2.163155e-5 |
GO:0032094 | response to food | 2.205419e-5 |
GO:0008057 | eye pigment granule organization | 2.555124e-5 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 2.565202e-5 |
GO:0030277 | maintenance of gastrointestinal epithelium | 2.603784e-5 |
GO:0042093 | T-helper cell differentiation | 2.772769e-5 |
GO:0009886 | post-embryonic morphogenesis | 2.826533e-5 |
GO:0006399 | tRNA metabolic process | 2.952553e-5 |
GO:0006363 | termination of RNA polymerase I transcription | 2.960657e-5 |
GO:0070309 | lens fiber cell morphogenesis | 2.996751e-5 |
GO:0031284 | positive regulation of guanylate cyclase activity | 3.022723e-5 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.106173e-5 |
GO:0060020 | Bergmann glial cell differentiation | 3.142775e-5 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 3.169401e-5 |
GO:0006424 | glutamyl-tRNA aminoacylation | 3.655703e-5 |
GO:0002440 | production of molecular mediator of immune response | 4.308038e-5 |
GO:0034633 | retinol transport | 4.379960e-5 |
GO:0071322 | cellular response to carbohydrate stimulus | 4.453638e-5 |
GO:0070301 | cellular response to hydrogen peroxide | 4.475945e-5 |
GO:0050769 | positive regulation of neurogenesis | 5.049809e-5 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 5.085072e-5 |
GO:0030198 | extracellular matrix organization | 5.108845e-5 |
GO:0043985 | histone H4-R3 methylation | 5.295183e-5 |
GO:0006685 | sphingomyelin catabolic process | 5.295183e-5 |
GO:0050803 | regulation of synapse structure and activity | 5.608266e-5 |
GO:0001878 | response to yeast | 5.646292e-5 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 5.971208e-5 |
GO:0070857 | regulation of bile acid biosynthetic process | 6.385839e-5 |
GO:2000210 | positive regulation of anoikis | 6.616360e-5 |
GO:0070307 | lens fiber cell development | 7.084350e-5 |
GO:0006422 | aspartyl-tRNA aminoacylation | 7.266669e-5 |
GO:0060251 | regulation of glial cell proliferation | 7.618785e-5 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 8.113304e-5 |
GO:0048524 | positive regulation of viral reproduction | 8.245281e-5 |
GO:0035246 | peptidyl-arginine N-methylation | 8.369321e-5 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 9.163848e-5 |
GO:0006937 | regulation of muscle contraction | 9.208296e-5 |
GO:0030903 | notochord development | 9.221429e-5 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 9.238875e-5 |
GO:0048320 | axial mesoderm formation | 1.008217e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.032833e-4 |
GO:0051238 | sequestering of metal ion | 1.044346e-4 |
GO:0071218 | cellular response to misfolded protein | 1.136222e-4 |
GO:0045351 | type I interferon biosynthetic process | 1.158878e-4 |
GO:0031064 | negative regulation of histone deacetylation | 1.191169e-4 |
GO:0070345 | negative regulation of fat cell proliferation | 1.213431e-4 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 1.228607e-4 |
GO:0000239 | pachytene | 1.278958e-4 |
GO:0060713 | labyrinthine layer morphogenesis | 1.312798e-4 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.320241e-4 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 1.427452e-4 |
GO:0010994 | free ubiquitin chain polymerization | 1.427452e-4 |
GO:0061077 | chaperone-mediated protein folding | 1.431058e-4 |
GO:0034470 | ncRNA processing | 1.459265e-4 |
GO:0019395 | fatty acid oxidation | 1.466863e-4 |
GO:0001970 | positive regulation of activation of membrane attack complex | 1.488455e-4 |
GO:0044089 | positive regulation of cellular component biogenesis | 1.497278e-4 |
GO:0060343 | trabecula formation | 1.579684e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.580475e-4 |
GO:0019254 | carnitine metabolic process, CoA-linked | 1.598454e-4 |
GO:0007623 | circadian rhythm | 1.614268e-4 |
GO:0090181 | regulation of cholesterol metabolic process | 1.624239e-4 |
GO:0043482 | cellular pigment accumulation | 1.663954e-4 |
GO:0043476 | pigment accumulation | 1.663954e-4 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.700814e-4 |
GO:0032964 | collagen biosynthetic process | 1.753557e-4 |
GO:0019217 | regulation of fatty acid metabolic process | 1.766015e-4 |
GO:0046724 | oxalic acid secretion | 1.801444e-4 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.801444e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.809518e-4 |
GO:0032008 | positive regulation of TOR signaling cascade | 1.868414e-4 |
GO:0090257 | regulation of muscle system process | 1.972284e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.973310e-4 |
GO:0048561 | establishment of organ orientation | 1.979448e-4 |
GO:0046731 | passive induction of host immune response by virus | 1.979448e-4 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 2.079494e-4 |
GO:0010720 | positive regulation of cell development | 2.112048e-4 |
GO:0008286 | insulin receptor signaling pathway | 2.115107e-4 |
GO:0042376 | phylloquinone catabolic process | 2.121634e-4 |
GO:0032074 | negative regulation of nuclease activity | 2.121634e-4 |
GO:0032474 | otolith morphogenesis | 2.121634e-4 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 2.147758e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 2.155066e-4 |
GO:0048319 | axial mesoderm morphogenesis | 2.287697e-4 |
GO:0048706 | embryonic skeletal system development | 2.288317e-4 |
GO:0070198 | protein localization to chromosome, telomeric region | 2.378785e-4 |
GO:0051965 | positive regulation of synapse assembly | 2.395110e-4 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.467295e-4 |
GO:0014040 | positive regulation of Schwann cell differentiation | 2.489336e-4 |
GO:0001678 | cellular glucose homeostasis | 2.498233e-4 |
GO:0009749 | response to glucose stimulus | 2.503252e-4 |
GO:0060561 | apoptosis involved in morphogenesis | 2.542616e-4 |
GO:0060041 | retina development in camera-type eye | 2.571322e-4 |
GO:0060711 | labyrinthine layer development | 2.601431e-4 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 2.601911e-4 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 2.726783e-4 |
GO:0035470 | positive regulation of vascular wound healing | 2.726783e-4 |
GO:0006546 | glycine catabolic process | 2.744234e-4 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 2.771282e-4 |
GO:0002645 | positive regulation of tolerance induction | 2.812382e-4 |
GO:0031929 | TOR signaling cascade | 2.960248e-4 |
GO:0006880 | intracellular sequestering of iron ion | 2.989459e-4 |
GO:0034379 | very-low-density lipoprotein particle assembly | 3.243514e-4 |
GO:0006298 | mismatch repair | 3.288044e-4 |
GO:0035883 | enteroendocrine cell differentiation | 3.406066e-4 |
GO:0061383 | trabecula morphogenesis | 3.436765e-4 |
GO:0006555 | methionine metabolic process | 3.460603e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 3.558562e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 3.558562e-4 |
GO:0009746 | response to hexose stimulus | 3.598006e-4 |
GO:0018200 | peptidyl-glutamic acid modification | 3.734871e-4 |
GO:0034284 | response to monosaccharide stimulus | 3.942030e-4 |
GO:0034447 | very-low-density lipoprotein particle clearance | 4.068007e-4 |
GO:0014813 | satellite cell commitment | 4.091817e-4 |
GO:0045820 | negative regulation of glycolysis | 4.110939e-4 |
GO:0090009 | primitive streak formation | 4.166176e-4 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 4.199479e-4 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 4.214109e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 4.280332e-4 |
GO:0019430 | removal of superoxide radicals | 4.280739e-4 |
GO:0032006 | regulation of TOR signaling cascade | 4.303168e-4 |
GO:0001839 | neural plate morphogenesis | 4.348630e-4 |
GO:0015670 | carbon dioxide transport | 4.398223e-4 |
GO:0060166 | olfactory pit development | 4.417375e-4 |
GO:0048515 | spermatid differentiation | 4.434615e-4 |
GO:0006471 | protein ADP-ribosylation | 4.486767e-4 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 4.537208e-4 |
GO:0005981 | regulation of glycogen catabolic process | 4.596437e-4 |
GO:0010894 | negative regulation of steroid biosynthetic process | 4.616813e-4 |
GO:0019542 | propionate biosynthetic process | 4.784758e-4 |
GO:0019413 | acetate biosynthetic process | 4.784758e-4 |
GO:0045109 | intermediate filament organization | 5.007692e-4 |
GO:0014740 | negative regulation of muscle hyperplasia | 5.121045e-4 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 5.254715e-4 |
GO:0060349 | bone morphogenesis | 5.277103e-4 |
GO:0051298 | centrosome duplication | 5.395541e-4 |
GO:0032025 | response to cobalt ion | 5.875388e-4 |
GO:0048146 | positive regulation of fibroblast proliferation | 6.007603e-4 |
GO:0008210 | estrogen metabolic process | 6.134619e-4 |
GO:2000209 | regulation of anoikis | 6.151028e-4 |
GO:0006821 | chloride transport | 6.400265e-4 |
GO:0046015 | regulation of transcription by glucose | 6.594619e-4 |
GO:0032606 | type I interferon production | 6.594619e-4 |
GO:0006282 | regulation of DNA repair | 6.770033e-4 |
GO:0006564 | L-serine biosynthetic process | 6.995853e-4 |
GO:0046599 | regulation of centriole replication | 6.997509e-4 |
GO:0043923 | positive regulation by host of viral transcription | 7.091855e-4 |
GO:0006760 | folic acid-containing compound metabolic process | 7.114282e-4 |
GO:0055114 | oxidation-reduction process | 7.329266e-4 |
GO:0045939 | negative regulation of steroid metabolic process | 7.338698e-4 |
GO:0006565 | L-serine catabolic process | 7.457080e-4 |
GO:0042073 | intraflagellar transport | 7.743992e-4 |
GO:0042758 | long-chain fatty acid catabolic process | 7.743992e-4 |
GO:0042413 | carnitine catabolic process | 7.743992e-4 |
GO:0070922 | small RNA loading onto RISC | 7.811210e-4 |
GO:0030047 | actin modification | 7.811210e-4 |
GO:0031282 | regulation of guanylate cyclase activity | 7.868194e-4 |
GO:0061144 | alveolar secondary septum development | 7.904271e-4 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 7.904271e-4 |
GO:0060096 | serotonin secretion, neurotransmission | 7.904271e-4 |
GO:0000303 | response to superoxide | 7.958180e-4 |
GO:0060347 | heart trabecula formation | 8.016452e-4 |
GO:0002579 | positive regulation of antigen processing and presentation | 8.047663e-4 |
GO:0009062 | fatty acid catabolic process | 8.077279e-4 |
GO:0045064 | T-helper 2 cell differentiation | 8.198889e-4 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 8.198889e-4 |
GO:0002315 | marginal zone B cell differentiation | 8.198889e-4 |
GO:0045338 | farnesyl diphosphate metabolic process | 8.221401e-4 |
GO:0032369 | negative regulation of lipid transport | 8.234978e-4 |
GO:0032792 | negative regulation of CREB transcription factor activity | 8.250945e-4 |
GO:0034440 | lipid oxidation | 8.421670e-4 |
GO:0009637 | response to blue light | 8.444052e-4 |
GO:0090150 | establishment of protein localization in membrane | 8.472026e-4 |
GO:0050807 | regulation of synapse organization | 8.485390e-4 |
GO:0071670 | smooth muscle cell chemotaxis | 8.496179e-4 |
GO:0072553 | terminal button organization | 8.496179e-4 |
GO:0060981 | cell migration involved in coronary angiogenesis | 8.496179e-4 |
GO:0016233 | telomere capping | 8.534286e-4 |
GO:0046320 | regulation of fatty acid oxidation | 8.556805e-4 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 8.619914e-4 |
GO:0033574 | response to testosterone stimulus | 8.729497e-4 |
GO:0002066 | columnar/cuboidal epithelial cell development | 9.034500e-4 |
GO:0040015 | negative regulation of multicellular organism growth | 9.151945e-4 |
GO:0048569 | post-embryonic organ development | 9.239000e-4 |
GO:0044027 | hypermethylation of CpG island | 9.369147e-4 |
GO:0090162 | establishment of epithelial cell polarity | 9.369147e-4 |
GO:0045909 | positive regulation of vasodilation | 9.401055e-4 |
GO:0042552 | myelination | 9.916275e-4 |
GO:0051919 | positive regulation of fibrinolysis | 1.024608e-3 |
GO:0060632 | regulation of microtubule-based movement | 1.035732e-3 |
GO:0010954 | positive regulation of protein processing | 1.040998e-3 |
GO:0001936 | regulation of endothelial cell proliferation | 1.048341e-3 |
GO:0048318 | axial mesoderm development | 1.059729e-3 |
GO:0015747 | urate transport | 1.108880e-3 |
GO:0007386 | compartment pattern specification | 1.110268e-3 |
GO:0010189 | vitamin E biosynthetic process | 1.114077e-3 |
GO:0019218 | regulation of steroid metabolic process | 1.147375e-3 |
GO:0051591 | response to cAMP | 1.170010e-3 |
GO:0006171 | cAMP biosynthetic process | 1.175058e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 1.182733e-3 |
GO:0031293 | membrane protein intracellular domain proteolysis | 1.204076e-3 |
GO:0006290 | pyrimidine dimer repair | 1.217954e-3 |
GO:0060621 | negative regulation of cholesterol import | 1.311240e-3 |
GO:0034614 | cellular response to reactive oxygen species | 1.314590e-3 |
GO:0048562 | embryonic organ morphogenesis | 1.319742e-3 |
GO:0009405 | pathogenesis | 1.345465e-3 |
GO:0001974 | blood vessel remodeling | 1.369627e-3 |
GO:0045739 | positive regulation of DNA repair | 1.374944e-3 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 1.396128e-3 |
GO:0071732 | cellular response to nitric oxide | 1.403734e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 1.428731e-3 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.458258e-3 |
GO:0045402 | regulation of interleukin-4 biosynthetic process | 1.469738e-3 |
GO:0060035 | notochord cell development | 1.487252e-3 |
GO:0006353 | transcription termination, DNA-dependent | 1.489263e-3 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 1.494839e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 1.535043e-3 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 1.552747e-3 |
GO:0051725 | protein de-ADP-ribosylation | 1.554770e-3 |
GO:0043503 | skeletal muscle fiber adaptation | 1.564731e-3 |
GO:0048705 | skeletal system morphogenesis | 1.578684e-3 |
GO:0010669 | epithelial structure maintenance | 1.579272e-3 |
GO:0042866 | pyruvate biosynthetic process | 1.583126e-3 |
GO:0030890 | positive regulation of B cell proliferation | 1.585754e-3 |
GO:0032922 | circadian regulation of gene expression | 1.592709e-3 |
GO:0045063 | T-helper 1 cell differentiation | 1.594937e-3 |
GO:0070208 | protein heterotrimerization | 1.620748e-3 |
GO:0035176 | social behavior | 1.634215e-3 |
GO:0002577 | regulation of antigen processing and presentation | 1.643973e-3 |
GO:0002367 | cytokine production involved in immune response | 1.655102e-3 |
GO:0072329 | monocarboxylic acid catabolic process | 1.673866e-3 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 1.694717e-3 |
GO:2000002 | negative regulation of DNA damage checkpoint | 1.694717e-3 |
GO:0021588 | cerebellum formation | 1.694717e-3 |
GO:0021551 | central nervous system morphogenesis | 1.694717e-3 |
GO:0007161 | calcium-independent cell-matrix adhesion | 1.694717e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 1.698691e-3 |
GO:0006942 | regulation of striated muscle contraction | 1.734172e-3 |
GO:0008355 | olfactory learning | 1.746916e-3 |
GO:0051291 | protein heterooligomerization | 1.764887e-3 |
GO:0000305 | response to oxygen radical | 1.768655e-3 |
GO:0072593 | reactive oxygen species metabolic process | 1.770708e-3 |
GO:0035854 | eosinophil fate commitment | 1.798686e-3 |
GO:0030222 | eosinophil differentiation | 1.798686e-3 |
GO:0030823 | regulation of cGMP metabolic process | 1.808272e-3 |
GO:0007286 | spermatid development | 1.866202e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 1.899653e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 1.976635e-3 |
GO:0097116 | gephyrin clustering | 1.978446e-3 |
GO:0035721 | intraflagellar retrograde transport | 1.986691e-3 |
GO:0001840 | neural plate development | 1.989249e-3 |
GO:0090311 | regulation of protein deacetylation | 2.079209e-3 |
GO:0042542 | response to hydrogen peroxide | 2.094051e-3 |
GO:0071233 | cellular response to leucine | 2.107621e-3 |
GO:0070914 | UV-damage excision repair | 2.107621e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 2.110699e-3 |
GO:0051963 | regulation of synapse assembly | 2.213725e-3 |
GO:0000917 | barrier septum formation | 2.228265e-3 |
GO:0006400 | tRNA modification | 2.232306e-3 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2.239860e-3 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 2.251260e-3 |
GO:0030953 | astral microtubule organization | 2.277604e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 2.289288e-3 |
GO:0051101 | regulation of DNA binding | 2.343529e-3 |
GO:0085020 | protein K6-linked ubiquitination | 2.370010e-3 |
GO:0010458 | exit from mitosis | 2.370010e-3 |
GO:0001938 | positive regulation of endothelial cell proliferation | 2.403518e-3 |
GO:0007289 | spermatid nucleus differentiation | 2.429819e-3 |
GO:0034660 | ncRNA metabolic process | 2.461441e-3 |
GO:0032365 | intracellular lipid transport | 2.468629e-3 |
GO:0002366 | leukocyte activation involved in immune response | 2.472498e-3 |
GO:0007296 | vitellogenesis | 2.501507e-3 |
GO:0060033 | anatomical structure regression | 2.505898e-3 |
GO:0061384 | heart trabecular morphogenesis | 2.535851e-3 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 2.535851e-3 |
GO:0070213 | protein auto-ADP-ribosylation | 2.559767e-3 |
GO:0014745 | negative regulation of muscle adaptation | 2.559767e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 2.575549e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 2.575549e-3 |
GO:0007371 | ventral midline determination | 2.575549e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 2.575549e-3 |
GO:0060620 | regulation of cholesterol import | 2.631468e-3 |
GO:0021592 | fourth ventricle development | 2.631468e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 2.637402e-3 |
GO:0002906 | negative regulation of mature B cell apoptosis | 2.638988e-3 |
GO:0031954 | positive regulation of protein autophosphorylation | 2.691219e-3 |
GO:0014002 | astrocyte development | 2.691219e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2.695770e-3 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.736898e-3 |
GO:0006601 | creatine biosynthetic process | 2.759383e-3 |
GO:0014738 | regulation of muscle hyperplasia | 2.873057e-3 |
GO:0002067 | glandular epithelial cell differentiation | 2.888065e-3 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 2.888981e-3 |
GO:0009785 | blue light signaling pathway | 2.922368e-3 |
GO:0050884 | neuromuscular process controlling posture | 2.940639e-3 |
GO:0048240 | sperm capacitation | 2.993484e-3 |
GO:0018209 | peptidyl-serine modification | 3.049707e-3 |
GO:0060872 | semicircular canal development | 3.052411e-3 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 3.074013e-3 |
GO:0019730 | antimicrobial humoral response | 3.074013e-3 |
GO:0002268 | follicular dendritic cell differentiation | 3.074013e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 3.135772e-3 |
GO:0021526 | medial motor column neuron differentiation | 3.145966e-3 |
GO:0070734 | histone H3-K27 methylation | 3.145966e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 3.145966e-3 |
GO:0003326 | pancreatic A cell fate commitment | 3.145966e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.188996e-3 |
GO:0048568 | embryonic organ development | 3.209179e-3 |
GO:0014015 | positive regulation of gliogenesis | 3.263331e-3 |
GO:0001892 | embryonic placenta development | 3.279194e-3 |
GO:0060999 | positive regulation of dendritic spine development | 3.282552e-3 |
GO:0032210 | regulation of telomere maintenance via telomerase | 3.282552e-3 |
GO:0016126 | sterol biosynthetic process | 3.350912e-3 |
GO:0033261 | regulation of S phase | 3.446483e-3 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 3.592731e-3 |
GO:0032375 | negative regulation of cholesterol transport | 3.639338e-3 |
GO:0032205 | negative regulation of telomere maintenance | 3.649049e-3 |
GO:0006289 | nucleotide-excision repair | 3.770295e-3 |
GO:0006600 | creatine metabolic process | 3.801263e-3 |
GO:0006013 | mannose metabolic process | 3.844673e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 3.851875e-3 |
GO:0009303 | rRNA transcription | 3.897908e-3 |
GO:0035587 | purinergic receptor signaling pathway | 3.911707e-3 |
GO:0051586 | positive regulation of dopamine uptake | 3.995564e-3 |
GO:0006884 | cell volume homeostasis | 4.027430e-3 |
GO:0006595 | polyamine metabolic process | 4.134825e-3 |
GO:0002426 | immunoglobulin production in mucosal tissue | 4.149202e-3 |
GO:0032933 | SREBP-mediated signaling pathway | 4.186335e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 4.219691e-3 |
GO:0002902 | regulation of B cell apoptosis | 4.219691e-3 |
GO:0002275 | myeloid cell activation involved in immune response | 4.255288e-3 |
GO:2000278 | regulation of DNA biosynthetic process | 4.301288e-3 |
GO:0006386 | termination of RNA polymerase III transcription | 4.323167e-3 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 4.323167e-3 |
GO:0071731 | response to nitric oxide | 4.362959e-3 |
GO:0048791 | calcium ion-dependent exocytosis of neurotransmitter | 4.363936e-3 |
GO:0016075 | rRNA catabolic process | 4.363936e-3 |
GO:0097119 | postsynaptic density protein 95 clustering | 4.366137e-3 |
GO:0032206 | positive regulation of telomere maintenance | 4.366137e-3 |
GO:0097104 | postsynaptic membrane assembly | 4.366137e-3 |
GO:0008366 | axon ensheathment | 4.406373e-3 |
GO:0010565 | regulation of cellular ketone metabolic process | 4.436735e-3 |
GO:0019264 | glycine biosynthetic process from serine | 4.467411e-3 |
GO:0042113 | B cell activation | 4.636147e-3 |
GO:0016125 | sterol metabolic process | 4.640569e-3 |
GO:0007020 | microtubule nucleation | 4.665247e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 4.691969e-3 |
GO:0035093 | spermatogenesis, exchange of chromosomal proteins | 4.691969e-3 |
GO:0061101 | neuroendocrine cell differentiation | 4.691969e-3 |
GO:0007189 | activation of adenylate cyclase activity by G-protein signaling pathway | 4.737053e-3 |
GO:0001955 | blood vessel maturation | 4.739293e-3 |
GO:0060395 | SMAD protein signal transduction | 4.743002e-3 |
GO:0060438 | trachea development | 4.795522e-3 |
GO:0051349 | positive regulation of lyase activity | 4.866756e-3 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 4.885533e-3 |
GO:0016246 | RNA interference | 4.906733e-3 |
GO:0030967 | ER-nuclear sterol response pathway | 4.945016e-3 |
GO:0090140 | regulation of mitochondrial fission | 4.949348e-3 |
GO:0070278 | extracellular matrix constituent secretion | 4.949348e-3 |
GO:0010260 | organ senescence | 4.949348e-3 |
GO:0000209 | protein polyubiquitination | 4.974362e-3 |
GO:0007141 | male meiosis I | 4.984040e-3 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 4.993970e-3 |
GO:0000387 | spliceosomal snRNP assembly | 4.993970e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 5.160535e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 5.177840e-3 |
GO:0097152 | mesenchymal cell apoptosis | 5.177840e-3 |
GO:0060982 | coronary artery morphogenesis | 5.177840e-3 |
GO:0035418 | protein localization to synapse | 5.212151e-3 |
GO:0060480 | lung goblet cell differentiation | 5.301913e-3 |
GO:0051289 | protein homotetramerization | 5.324026e-3 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 5.334717e-3 |
GO:0010830 | regulation of myotube differentiation | 5.388998e-3 |
GO:0050772 | positive regulation of axonogenesis | 5.448298e-3 |
GO:0042360 | vitamin E metabolic process | 5.463138e-3 |
GO:0042048 | olfactory behavior | 5.463138e-3 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 5.471042e-3 |
GO:0060348 | bone development | 5.493930e-3 |
GO:0048708 | astrocyte differentiation | 5.496407e-3 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 5.518767e-3 |
GO:0042396 | phosphagen biosynthetic process | 5.600713e-3 |
GO:0002377 | immunoglobulin production | 5.610953e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 5.625102e-3 |
GO:0034231 | islet amyloid polypeptide processing | 5.625102e-3 |
GO:0034230 | enkephalin processing | 5.625102e-3 |
GO:0000088 | mitotic prophase | 5.625102e-3 |
GO:0051973 | positive regulation of telomerase activity | 5.691777e-3 |
GO:0016090 | prenol metabolic process | 5.691777e-3 |
GO:0045404 | positive regulation of interleukin-4 biosynthetic process | 5.713726e-3 |
GO:0032869 | cellular response to insulin stimulus | 5.786911e-3 |
GO:0035166 | post-embryonic hemopoiesis | 5.951353e-3 |
GO:0002666 | positive regulation of T cell tolerance induction | 5.952647e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 6.073302e-3 |
GO:0002636 | positive regulation of germinal center formation | 6.073302e-3 |
GO:0030195 | negative regulation of blood coagulation | 6.107967e-3 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 6.146353e-3 |
GO:0046321 | positive regulation of fatty acid oxidation | 6.160988e-3 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 6.201921e-3 |
GO:0048592 | eye morphogenesis | 6.261563e-3 |
GO:0070212 | protein poly-ADP-ribosylation | 6.339293e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 6.339293e-3 |
GO:0033119 | negative regulation of RNA splicing | 6.367872e-3 |
GO:0002792 | negative regulation of peptide secretion | 6.419270e-3 |
GO:0002830 | positive regulation of type 2 immune response | 6.448618e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0000305 | response to oxygen radical | 3.076057e-10 |
GO:0019430 | removal of superoxide radicals | 2.880696e-8 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 3.127007e-8 |
GO:0050746 | regulation of lipoprotein metabolic process | 4.859468e-8 |
GO:0001957 | intramembranous ossification | 7.175316e-8 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 7.448505e-8 |
GO:0060350 | endochondral bone morphogenesis | 7.840327e-8 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 8.528357e-8 |
GO:0006260 | DNA replication | 1.521333e-7 |
GO:0000303 | response to superoxide | 1.998474e-7 |
GO:0006011 | UDP-glucose metabolic process | 2.159048e-7 |
GO:0034442 | regulation of lipoprotein oxidation | 2.498578e-7 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 3.109750e-7 |
GO:0046470 | phosphatidylcholine metabolic process | 3.856423e-7 |
GO:0001958 | endochondral ossification | 4.367930e-7 |
GO:0071267 | L-methionine salvage | 4.481747e-7 |
GO:0060349 | bone morphogenesis | 6.604379e-7 |
GO:0042572 | retinol metabolic process | 8.356093e-7 |
GO:0008612 | peptidyl-lysine modification to hypusine | 1.000229e-6 |
GO:0021903 | rostrocaudal neural tube patterning | 1.202935e-6 |
GO:0010896 | regulation of triglyceride catabolic process | 1.270884e-6 |
GO:0006259 | DNA metabolic process | 1.459791e-6 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.586010e-6 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 1.744441e-6 |
GO:0021993 | initiation of neural tube closure | 1.744441e-6 |
GO:0043691 | reverse cholesterol transport | 2.038918e-6 |
GO:0006801 | superoxide metabolic process | 2.069766e-6 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 3.125718e-6 |
GO:0051586 | positive regulation of dopamine uptake | 3.144632e-6 |
GO:0060343 | trabecula formation | 3.221113e-6 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 3.234332e-6 |
GO:0071218 | cellular response to misfolded protein | 3.284524e-6 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 3.533572e-6 |
GO:0015876 | acetyl-CoA transport | 3.829801e-6 |
GO:0031536 | positive regulation of exit from mitosis | 4.185049e-6 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 4.196719e-6 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 5.484766e-6 |
GO:0021532 | neural tube patterning | 5.581259e-6 |
GO:0016557 | peroxisome membrane biogenesis | 5.669171e-6 |
GO:0016574 | histone ubiquitination | 6.278847e-6 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 7.246581e-6 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 7.852635e-6 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 8.258374e-6 |
GO:0042733 | embryonic digit morphogenesis | 8.584106e-6 |
GO:0061383 | trabecula morphogenesis | 9.389008e-6 |
GO:0010454 | negative regulation of cell fate commitment | 9.522180e-6 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.008568e-5 |
GO:0006270 | DNA-dependent DNA replication initiation | 1.008568e-5 |
GO:0001830 | trophectodermal cell fate commitment | 1.012627e-5 |
GO:0071103 | DNA conformation change | 1.179888e-5 |
GO:0061181 | regulation of chondrocyte development | 1.254568e-5 |
GO:0016559 | peroxisome fission | 1.277347e-5 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.634510e-5 |
GO:0034633 | retinol transport | 1.638142e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.874036e-5 |
GO:0002561 | basophil degranulation | 1.874036e-5 |
GO:0042304 | regulation of fatty acid biosynthetic process | 1.946047e-5 |
GO:0007130 | synaptonemal complex assembly | 1.953683e-5 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 2.094716e-5 |
GO:0055090 | acylglycerol homeostasis | 2.514586e-5 |
GO:0048483 | autonomic nervous system development | 2.541608e-5 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 2.716605e-5 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 2.732157e-5 |
GO:0006807 | nitrogen compound metabolic process | 2.748063e-5 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 2.878542e-5 |
GO:0048368 | lateral mesoderm development | 2.996545e-5 |
GO:0060644 | mammary gland epithelial cell differentiation | 3.153086e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.236827e-5 |
GO:0060346 | bone trabecula formation | 3.358712e-5 |
GO:0031396 | regulation of protein ubiquitination | 3.557759e-5 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 3.590241e-5 |
GO:0000413 | protein peptidyl-prolyl isomerization | 3.688301e-5 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 3.762098e-5 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 3.965911e-5 |
GO:0000492 | box C/D snoRNP assembly | 4.058940e-5 |
GO:0032423 | regulation of mismatch repair | 4.202904e-5 |
GO:0090304 | nucleic acid metabolic process | 4.288108e-5 |
GO:0006417 | regulation of translation | 4.297264e-5 |
GO:0006434 | seryl-tRNA aminoacylation | 4.488342e-5 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 4.899030e-5 |
GO:0051182 | coenzyme transport | 5.224035e-5 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 5.224035e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.224035e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.224035e-5 |
GO:0072337 | modified amino acid transport | 5.294406e-5 |
GO:0003350 | pulmonary myocardium development | 6.308336e-5 |
GO:0002507 | tolerance induction | 6.575798e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 6.695699e-5 |
GO:0070193 | synaptonemal complex organization | 6.934331e-5 |
GO:0006457 | protein folding | 6.946599e-5 |
GO:0060012 | synaptic transmission, glycinergic | 7.368159e-5 |
GO:0006982 | response to lipid hydroperoxide | 7.553874e-5 |
GO:0031943 | regulation of glucocorticoid metabolic process | 7.761157e-5 |
GO:0042254 | ribosome biogenesis | 7.980224e-5 |
GO:0070327 | thyroid hormone transport | 8.261879e-5 |
GO:0006412 | translation | 8.337812e-5 |
GO:0046502 | uroporphyrinogen III metabolic process | 8.410815e-5 |
GO:0000279 | M phase | 8.903611e-5 |
GO:0006414 | translational elongation | 9.223931e-5 |
GO:0060621 | negative regulation of cholesterol import | 9.780609e-5 |
GO:0018208 | peptidyl-proline modification | 9.847382e-5 |
GO:0034375 | high-density lipoprotein particle remodeling | 9.915505e-5 |
GO:0009950 | dorsal/ventral axis specification | 9.984889e-5 |
GO:0030917 | midbrain-hindbrain boundary development | 1.015875e-4 |
GO:0002335 | mature B cell differentiation | 1.015875e-4 |
GO:0034587 | piRNA metabolic process | 1.086118e-4 |
GO:0031946 | regulation of glucocorticoid biosynthetic process | 1.086118e-4 |
GO:0010608 | posttranscriptional regulation of gene expression | 1.109197e-4 |
GO:0045575 | basophil activation | 1.128597e-4 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 1.128597e-4 |
GO:0009236 | cobalamin biosynthetic process | 1.128597e-4 |
GO:0006409 | tRNA export from nucleus | 1.128597e-4 |
GO:0021572 | rhombomere 6 development | 1.149996e-4 |
GO:0040029 | regulation of gene expression, epigenetic | 1.163262e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 1.216185e-4 |
GO:0010720 | positive regulation of cell development | 1.253478e-4 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.263871e-4 |
GO:0070079 | histone H4-R3 demethylation | 1.320191e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.320191e-4 |
GO:0070078 | histone H3-R2 demethylation | 1.320191e-4 |
GO:0007128 | meiotic prophase I | 1.409901e-4 |
GO:0030300 | regulation of intestinal cholesterol absorption | 1.464633e-4 |
GO:0042744 | hydrogen peroxide catabolic process | 1.552421e-4 |
GO:0051788 | response to misfolded protein | 1.556201e-4 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 1.574380e-4 |
GO:0045581 | negative regulation of T cell differentiation | 1.618718e-4 |
GO:0031397 | negative regulation of protein ubiquitination | 1.743318e-4 |
GO:0006415 | translational termination | 1.761422e-4 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 1.825886e-4 |
GO:0071044 | histone mRNA catabolic process | 1.846519e-4 |
GO:0016458 | gene silencing | 1.848623e-4 |
GO:0006642 | triglyceride mobilization | 1.854465e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.912817e-4 |
GO:0060897 | neural plate regionalization | 1.927475e-4 |
GO:0031047 | gene silencing by RNA | 1.996118e-4 |
GO:0035518 | histone H2A monoubiquitination | 2.085524e-4 |
GO:0042439 | ethanolamine-containing compound metabolic process | 2.188316e-4 |
GO:0001706 | endoderm formation | 2.218648e-4 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 2.226466e-4 |
GO:0034505 | tooth mineralization | 2.259959e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.267898e-4 |
GO:0070368 | positive regulation of hepatocyte differentiation | 2.313030e-4 |
GO:0002320 | lymphoid progenitor cell differentiation | 2.366831e-4 |
GO:0070192 | chromosome organization involved in meiosis | 2.384077e-4 |
GO:0006323 | DNA packaging | 2.396827e-4 |
GO:0046503 | glycerolipid catabolic process | 2.451878e-4 |
GO:0048484 | enteric nervous system development | 2.714902e-4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 2.939717e-4 |
GO:0072110 | glomerular mesangial cell proliferation | 2.963654e-4 |
GO:0048706 | embryonic skeletal system development | 3.034267e-4 |
GO:0001947 | heart looping | 3.138460e-4 |
GO:0033522 | histone H2A ubiquitination | 3.207167e-4 |
GO:0019433 | triglyceride catabolic process | 3.306715e-4 |
GO:0060620 | regulation of cholesterol import | 3.346558e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 3.381535e-4 |
GO:0051639 | actin filament network formation | 3.522723e-4 |
GO:0045727 | positive regulation of translation | 3.604506e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 3.717143e-4 |
GO:0050928 | negative regulation of positive chemotaxis | 3.885974e-4 |
GO:0001579 | medium-chain fatty acid transport | 3.885974e-4 |
GO:0006258 | UDP-glucose catabolic process | 3.885974e-4 |
GO:0060841 | venous blood vessel development | 4.109360e-4 |
GO:0051580 | regulation of neurotransmitter uptake | 4.191002e-4 |
GO:0006809 | nitric oxide biosynthetic process | 4.191002e-4 |
GO:0002679 | respiratory burst involved in defense response | 4.191002e-4 |
GO:0006446 | regulation of translational initiation | 4.332520e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.409720e-4 |
GO:0021678 | third ventricle development | 4.411467e-4 |
GO:0070307 | lens fiber cell development | 4.433366e-4 |
GO:0032353 | negative regulation of hormone biosynthetic process | 4.467872e-4 |
GO:0071827 | plasma lipoprotein particle organization | 4.628858e-4 |
GO:0009996 | negative regulation of cell fate specification | 4.742342e-4 |
GO:0010812 | negative regulation of cell-substrate adhesion | 4.811706e-4 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 5.008155e-4 |
GO:0006695 | cholesterol biosynthetic process | 5.152695e-4 |
GO:0008535 | respiratory chain complex IV assembly | 5.257334e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 5.403492e-4 |
GO:0035621 | ER to Golgi ceramide transport | 5.461282e-4 |
GO:0000237 | leptotene | 5.461282e-4 |
GO:0002227 | innate immune response in mucosa | 5.479873e-4 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 5.758099e-4 |
GO:0060282 | positive regulation of oocyte development | 5.816624e-4 |
GO:0060281 | regulation of oocyte development | 5.816624e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 5.859902e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 5.876918e-4 |
GO:0016078 | tRNA catabolic process | 5.962957e-4 |
GO:0001682 | tRNA 5'-leader removal | 5.962957e-4 |
GO:0090136 | epithelial cell-cell adhesion | 6.033194e-4 |
GO:0006482 | protein demethylation | 6.168222e-4 |
GO:0046464 | acylglycerol catabolic process | 6.304126e-4 |
GO:0032119 | sequestering of zinc ion | 6.325591e-4 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 6.633323e-4 |
GO:0051351 | positive regulation of ligase activity | 7.258176e-4 |
GO:0016090 | prenol metabolic process | 7.267189e-4 |
GO:0006448 | regulation of translational elongation | 7.510205e-4 |
GO:0043584 | nose development | 7.564816e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.629715e-4 |
GO:0021592 | fourth ventricle development | 7.676566e-4 |
GO:0030953 | astral microtubule organization | 7.740202e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 7.843162e-4 |
GO:0071506 | cellular response to mycophenolic acid | 8.060180e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 8.060180e-4 |
GO:0071712 | ER-associated misfolded protein catabolic process | 8.109029e-4 |
GO:0070328 | triglyceride homeostasis | 9.378338e-4 |
GO:0007126 | meiosis | 9.392722e-4 |
GO:0017148 | negative regulation of translation | 9.443292e-4 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 9.568447e-4 |
GO:0003401 | axis elongation | 9.608685e-4 |
GO:0010390 | histone monoubiquitination | 9.675865e-4 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 1.004076e-3 |
GO:0071247 | cellular response to chromate | 1.004076e-3 |
GO:0046108 | uridine metabolic process | 1.004076e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 1.004076e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.018147e-3 |
GO:0007129 | synapsis | 1.019178e-3 |
GO:0006334 | nucleosome assembly | 1.020838e-3 |
GO:0065005 | protein-lipid complex assembly | 1.064097e-3 |
GO:0006577 | betaine metabolic process | 1.079366e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.079410e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.079410e-3 |
GO:0034421 | post-translational protein acetylation | 1.079410e-3 |
GO:0006428 | isoleucyl-tRNA aminoacylation | 1.079410e-3 |
GO:0045947 | negative regulation of translational initiation | 1.085297e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 1.125881e-3 |
GO:0051216 | cartilage development | 1.127636e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 1.132261e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 1.133497e-3 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.172296e-3 |
GO:0033083 | regulation of immature T cell proliferation | 1.189047e-3 |
GO:0043550 | regulation of lipid kinase activity | 1.193156e-3 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 1.199194e-3 |
GO:0008354 | germ cell migration | 1.209226e-3 |
GO:0044319 | wound healing, spreading of cells | 1.227289e-3 |
GO:0007096 | regulation of exit from mitosis | 1.228283e-3 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 1.271069e-3 |
GO:0010656 | negative regulation of muscle cell apoptosis | 1.296720e-3 |
GO:0009799 | specification of symmetry | 1.309683e-3 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 1.324678e-3 |
GO:0000726 | non-recombinational repair | 1.340616e-3 |
GO:0002328 | pro-B cell differentiation | 1.349965e-3 |
GO:0002268 | follicular dendritic cell differentiation | 1.357173e-3 |
GO:0060914 | heart formation | 1.397232e-3 |
GO:0014002 | astrocyte development | 1.477420e-3 |
GO:0060896 | neural plate pattern specification | 1.487564e-3 |
GO:0009059 | macromolecule biosynthetic process | 1.501312e-3 |
GO:0045905 | positive regulation of translational termination | 1.506557e-3 |
GO:0006452 | translational frameshifting | 1.506557e-3 |
GO:0045901 | positive regulation of translational elongation | 1.506557e-3 |
GO:0045454 | cell redox homeostasis | 1.512653e-3 |
GO:0016199 | axon midline choice point recognition | 1.541763e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 1.599974e-3 |
GO:0030046 | parallel actin filament bundle assembly | 1.666260e-3 |
GO:0035524 | proline transmembrane transport | 1.705678e-3 |
GO:0035634 | response to stilbenoid | 1.746975e-3 |
GO:0035967 | cellular response to topologically incorrect protein | 1.754316e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.759536e-3 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 1.759536e-3 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.762531e-3 |
GO:0021513 | spinal cord dorsal/ventral patterning | 1.793686e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.796295e-3 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 1.797565e-3 |
GO:0044091 | membrane biogenesis | 1.798866e-3 |
GO:0034241 | positive regulation of macrophage fusion | 1.804886e-3 |
GO:0010189 | vitamin E biosynthetic process | 1.804886e-3 |
GO:0046434 | organophosphate catabolic process | 1.812721e-3 |
GO:0021511 | spinal cord patterning | 1.838518e-3 |
GO:0010312 | detoxification of zinc ion | 1.851149e-3 |
GO:0034614 | cellular response to reactive oxygen species | 1.887334e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 1.921313e-3 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 1.942190e-3 |
GO:0009309 | amine biosynthetic process | 2.033563e-3 |
GO:0048521 | negative regulation of behavior | 2.050377e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 2.096442e-3 |
GO:0003127 | detection of nodal flow | 2.096442e-3 |
GO:0018126 | protein hydroxylation | 2.170825e-3 |
GO:0019987 | negative regulation of anti-apoptosis | 2.174689e-3 |
GO:0003002 | regionalization | 2.181833e-3 |
GO:0044085 | cellular component biogenesis | 2.224927e-3 |
GO:0006268 | DNA unwinding involved in replication | 2.244818e-3 |
GO:0044106 | cellular amine metabolic process | 2.284048e-3 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.379908e-3 |
GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning | 2.385827e-3 |
GO:0055119 | relaxation of cardiac muscle | 2.389896e-3 |
GO:0051321 | meiotic cell cycle | 2.408463e-3 |
GO:0002536 | respiratory burst involved in inflammatory response | 2.422283e-3 |
GO:0051066 | dihydrobiopterin metabolic process | 2.422283e-3 |
GO:0061180 | mammary gland epithelium development | 2.534582e-3 |
GO:0060348 | bone development | 2.562208e-3 |
GO:0016070 | RNA metabolic process | 2.597038e-3 |
GO:0007492 | endoderm development | 2.603479e-3 |
GO:0021563 | glossopharyngeal nerve development | 2.813637e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 2.816422e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 2.816422e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.854245e-3 |
GO:0071361 | cellular response to ethanol | 2.977530e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 2.999565e-3 |
GO:0018343 | protein farnesylation | 2.999565e-3 |
GO:0060286 | flagellar cell motility | 2.999565e-3 |
GO:0021999 | neural plate anterior/posterior regionalization | 3.032002e-3 |
GO:0060968 | regulation of gene silencing | 3.038251e-3 |
GO:0055070 | copper ion homeostasis | 3.067527e-3 |
GO:0030150 | protein import into mitochondrial matrix | 3.068301e-3 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 3.068301e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 3.068301e-3 |
GO:0018872 | arsonoacetate metabolic process | 3.068301e-3 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 3.068301e-3 |
GO:0021670 | lateral ventricle development | 3.074141e-3 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 3.080956e-3 |
GO:0015879 | carnitine transport | 3.131995e-3 |
GO:0045338 | farnesyl diphosphate metabolic process | 3.166181e-3 |
GO:0007030 | Golgi organization | 3.176808e-3 |
GO:0021544 | subpallium development | 3.178535e-3 |
GO:0046323 | glucose import | 3.183595e-3 |
GO:0060013 | righting reflex | 3.207669e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 3.282131e-3 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 3.307660e-3 |
GO:0090192 | regulation of glomerulus development | 3.361884e-3 |
GO:0042476 | odontogenesis | 3.372230e-3 |
GO:0002385 | mucosal immune response | 3.418117e-3 |
GO:0016577 | histone demethylation | 3.483332e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 3.605192e-3 |
GO:0042938 | dipeptide transport | 3.605192e-3 |
GO:0045628 | regulation of T-helper 2 cell differentiation | 3.679372e-3 |
GO:0002313 | mature B cell differentiation involved in immune response | 3.685604e-3 |
GO:0022403 | cell cycle phase | 3.737172e-3 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 3.809001e-3 |
GO:0010467 | gene expression | 3.817719e-3 |
GO:0007368 | determination of left/right symmetry | 3.877589e-3 |
GO:0006278 | RNA-dependent DNA replication | 3.878114e-3 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 3.904008e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 4.015233e-3 |
GO:0016236 | macroautophagy | 4.023135e-3 |
GO:0070988 | demethylation | 4.038993e-3 |
GO:0048705 | skeletal system morphogenesis | 4.040367e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 4.052273e-3 |
GO:0051340 | regulation of ligase activity | 4.068777e-3 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 4.103766e-3 |
GO:0046639 | negative regulation of alpha-beta T cell differentiation | 4.113830e-3 |
GO:0021756 | striatum development | 4.163407e-3 |
GO:0070846 | Hsp90 deacetylation | 4.165366e-3 |
GO:0090042 | tubulin deacetylation | 4.165366e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 4.165366e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 4.165366e-3 |
GO:0002462 | tolerance induction to nonself antigen | 4.165366e-3 |
GO:0048496 | maintenance of organ identity | 4.185271e-3 |
GO:0035993 | deltoid tuberosity development | 4.185271e-3 |
GO:0061154 | endothelial tube morphogenesis | 4.203827e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 4.203827e-3 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 4.203827e-3 |
GO:0034227 | tRNA thio-modification | 4.203827e-3 |
GO:0006449 | regulation of translational termination | 4.203827e-3 |
GO:0072593 | reactive oxygen species metabolic process | 4.208215e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 4.245807e-3 |
GO:0032329 | serine transport | 4.246622e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 4.267847e-3 |
GO:0031122 | cytoplasmic microtubule organization | 4.305720e-3 |
GO:0035108 | limb morphogenesis | 4.312905e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 4.329876e-3 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 4.329876e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 4.633741e-3 |
GO:0010994 | free ubiquitin chain polymerization | 4.633741e-3 |
GO:0006413 | translational initiation | 4.676660e-3 |
GO:0060973 | cell migration involved in heart development | 4.793573e-3 |
GO:0000302 | response to reactive oxygen species | 4.808219e-3 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 4.836190e-3 |
GO:0006657 | CDP-choline pathway | 4.836190e-3 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 4.836190e-3 |
GO:2000136 | regulation of cell proliferation involved in heart morphogenesis | 4.884870e-3 |
GO:0090218 | positive regulation of lipid kinase activity | 4.918377e-3 |
GO:0051647 | nucleus localization | 5.014381e-3 |
GO:0032967 | positive regulation of collagen biosynthetic process | 5.015615e-3 |
GO:0031497 | chromatin assembly | 5.017346e-3 |
GO:0032024 | positive regulation of insulin secretion | 5.176945e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.254424e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 5.264951e-3 |
GO:0042743 | hydrogen peroxide metabolic process | 5.275508e-3 |
GO:0003215 | cardiac right ventricle morphogenesis | 5.275508e-3 |
GO:0016126 | sterol biosynthetic process | 5.275508e-3 |
GO:0090208 | positive regulation of triglyceride metabolic process | 5.425394e-3 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 5.426201e-3 |
GO:0051238 | sequestering of metal ion | 5.426201e-3 |
GO:0030261 | chromosome condensation | 5.455658e-3 |
GO:0061316 | canonical Wnt receptor signaling pathway involved in heart development | 5.603214e-3 |
GO:0072498 | embryonic skeletal joint development | 5.656703e-3 |
GO:0006261 | DNA-dependent DNA replication | 5.667101e-3 |
GO:0097070 | ductus arteriosus closure | 5.685845e-3 |
GO:0065004 | protein-DNA complex assembly | 5.723092e-3 |
GO:0009107 | lipoate biosynthetic process | 5.815251e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 5.815251e-3 |
GO:0002251 | organ or tissue specific immune response | 5.839440e-3 |
GO:0006999 | nuclear pore organization | 5.874404e-3 |
GO:0044260 | cellular macromolecule metabolic process | 5.876711e-3 |
GO:0008334 | histone mRNA metabolic process | 5.883699e-3 |
GO:0006304 | DNA modification | 5.894365e-3 |
GO:0034728 | nucleosome organization | 5.900517e-3 |
GO:0070544 | histone H3-K36 demethylation | 6.001546e-3 |
GO:0006720 | isoprenoid metabolic process | 6.106023e-3 |
GO:0061311 | cell surface receptor linked signaling pathway involved in heart development | 6.106741e-3 |
GO:0000239 | pachytene | 6.121486e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 6.440231e-3 |
GO:0002315 | marginal zone B cell differentiation | 6.440231e-3 |
GO:0070306 | lens fiber cell differentiation | 6.741039e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 6.790243e-3 |
GO:0021521 | ventral spinal cord interneuron specification | 6.825778e-3 |
GO:0035990 | tendon cell differentiation | 6.872094e-3 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 6.872094e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 6.992105e-3 |
GO:0018193 | peptidyl-amino acid modification | 7.019055e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 7.081652e-3 |
GO:0006713 | glucocorticoid catabolic process | 7.081652e-3 |
GO:0003241 | growth involved in heart morphogenesis | 7.081652e-3 |
GO:0006306 | DNA methylation | 7.120592e-3 |
GO:0070979 | protein K11-linked ubiquitination | 7.210209e-3 |
GO:0070301 | cellular response to hydrogen peroxide | 7.214230e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 7.281851e-3 |
GO:0060272 | embryonic skeletal joint morphogenesis | 7.317683e-3 |
GO:0045661 | regulation of myoblast differentiation | 7.319156e-3 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 7.406464e-3 |
GO:0035066 | positive regulation of histone acetylation | 7.414124e-3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 7.414432e-3 |
GO:0032055 | negative regulation of translation in response to stress | 7.517546e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 7.579385e-3 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 7.590409e-3 |
GO:0061324 | canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation | 7.590409e-3 |
GO:0015825 | L-serine transport | 7.590409e-3 |
GO:0007412 | axon target recognition | 7.590409e-3 |
GO:0001755 | neural crest cell migration | 7.605754e-3 |
GO:0060592 | mammary gland formation | 7.675155e-3 |
GO:0032691 | negative regulation of interleukin-1 beta production | 7.680250e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 7.968238e-3 |
GO:0051148 | negative regulation of muscle cell differentiation | 7.970362e-3 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 8.001691e-3 |
GO:0032474 | otolith morphogenesis | 8.012312e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 8.012312e-3 |
GO:0065002 | intracellular protein transmembrane transport | 8.012312e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 8.012312e-3 |
GO:0003210 | cardiac atrium formation | 8.012312e-3 |
GO:0003236 | sinus venosus morphogenesis | 8.012312e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 8.012312e-3 |
GO:0006662 | glycerol ether metabolic process | 8.045986e-3 |
GO:0090239 | regulation of histone H4 acetylation | 8.116979e-3 |
GO:0060174 | limb bud formation | 8.170186e-3 |
GO:0002052 | positive regulation of neuroblast proliferation | 8.277098e-3 |
GO:0006878 | cellular copper ion homeostasis | 8.294113e-3 |
GO:0034660 | ncRNA metabolic process | 8.302104e-3 |
GO:0001825 | blastocyst formation | 8.365300e-3 |
GO:0051181 | cofactor transport | 8.398767e-3 |
GO:0032314 | regulation of Rac GTPase activity | 8.478817e-3 |
GO:0006089 | lactate metabolic process | 8.494308e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 8.528815e-3 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.729075e-3 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 8.779935e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 8.898441e-3 |
GO:0006273 | lagging strand elongation | 8.898441e-3 |
GO:0060480 | lung goblet cell differentiation | 8.898441e-3 |
GO:0044241 | lipid digestion | 9.002840e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 9.282110e-3 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 9.488596e-3 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 9.551559e-3 |
GO:0034621 | cellular macromolecular complex subunit organization | 9.564968e-3 |
GO:0060068 | vagina development | 9.590974e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 9.657967e-3 |
GO:0051645 | Golgi localization | 9.676915e-3 |
GO:0072109 | glomerular mesangium development | 9.676915e-3 |
GO:0060433 | bronchus development | 9.760559e-3 |
GO:0018342 | protein prenylation | 9.796833e-3 |
GO:0021508 | floor plate formation | 9.838635e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 1.013766e-2 |
GO:0043932 | ossification involved in bone remodeling | 1.017324e-2 |
GO:0006561 | proline biosynthetic process | 1.017324e-2 |
GO:0033505 | floor plate morphogenesis | 1.017324e-2 |
GO:0006081 | cellular aldehyde metabolic process | 1.021633e-2 |
GO:0051303 | establishment of chromosome localization | 1.022322e-2 |
GO:0003211 | cardiac ventricle formation | 1.031138e-2 |
GO:0045767 | regulation of anti-apoptosis | 1.042498e-2 |
GO:0032692 | negative regulation of interleukin-1 production | 1.046384e-2 |
GO:0003139 | secondary heart field specification | 1.052414e-2 |
GO:0060840 | artery development | 1.053179e-2 |
GO:0032508 | DNA duplex unwinding | 1.056836e-2 |
GO:0021773 | striatal medium spiny neuron differentiation | 1.056836e-2 |
GO:0018202 | peptidyl-histidine modification | 1.056836e-2 |
GO:0009437 | carnitine metabolic process | 1.056836e-2 |
GO:0008652 | cellular amino acid biosynthetic process | 1.062729e-2 |
GO:0050930 | induction of positive chemotaxis | 1.071415e-2 |
GO:0001569 | patterning of blood vessels | 1.075418e-2 |
GO:0001714 | endodermal cell fate specification | 1.091741e-2 |
GO:0001842 | neural fold formation | 1.091741e-2 |
GO:0048844 | artery morphogenesis | 1.105782e-2 |
GO:0032222 | regulation of synaptic transmission, cholinergic | 1.120823e-2 |
GO:0045669 | positive regulation of osteoblast differentiation | 1.121263e-2 |
GO:0006520 | cellular amino acid metabolic process | 1.124841e-2 |
GO:0002897 | positive regulation of central B cell tolerance induction | 1.135469e-2 |
GO:0072553 | terminal button organization | 1.135469e-2 |
GO:0002508 | central tolerance induction | 1.135469e-2 |
GO:0002125 | maternal aggressive behavior | 1.135469e-2 |
GO:0021591 | ventricular system development | 1.144815e-2 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.145176e-2 |
GO:0043056 | forward locomotion | 1.156841e-2 |
GO:0001935 | endothelial cell proliferation | 1.168048e-2 |
GO:0033574 | response to testosterone stimulus | 1.174238e-2 |